Adeno-associated viruses (AAVs) have become an important delivery platform in gene therapy applications due to their ability to transport genetic material into targeted cells. The primary objective of the landscape investigation was to identify the existing technology ecosystem surrounding automated AAV production and determine how closely available patent and non-patent literature aligned with the integrated system concept.
The investigated technology focused on an advanced automated AAV manufacturing workflow integrating sterile cell culture environments, robotic handling systems, imaging-based monitoring, and artificial intelligence-driven process optimization.